Company intelligence / Profile preview

Blue Arbor Technologies

Grass Lake, Michigan, United States

Ownership: Private
Development stage: Other

Overview

The RESTORE Neuromuscular Interface System, which directly connects a patient's peripheral nerves and muscles to advanced robotic prosthetics, has demonstrated long-term, stable signal capture and dexterous control in early human feasibility trials; it has received FDA Breakthrough Device Designation and is awaiting further pivotal/registration trials for commercialization.

Therapeutic areas: Other
Modalities: DeviceNeuroprosthetic interface
Industry: Assistive Medical Devices

Partnerships

Strategic investment by an (undisclosed) major lower limb prosthetic manufacturer

Beyond the preview

Go deeper on Blue Arbor Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Arbor Technologies.

Explore the full profile